Bibliography
- FEDER ME, HOFMANN GE: Heat-shock proteins, molecular chaperonins, and the stress response: evolutionary and ecological physiology. Ann. Rev. Physiol. (1999) 61:243-282.
- FRYDMAN J: Folding of newly translated proteins in vivo: the role of molecular chaperonins. Ann. Rev. Biochem. (2001) 70:603-647.
- HENDERSON B, ALLAN E, COATES AR: Stress wars: the direct role of host and bacterial molecular chaperonins in bacterial infection. Infect. Immun. (2006) 74:3693-3706.
- TSAN MF, GAO B: Heat shock protein and innate immunity. Cell Mol. Immunol. (2004) 1:274-279.
- HAUET-BROERE F, WIETEN L, GUICHELAAR T et al.: Heat shock proteins induce T cell regulation of chronic inflammation. Ann. Rheum. Dis. (2006) 65(Suppl. 3):65-68.
- PROHÁSZKA Z: Chaperonins as part of immune networks. Adv. Exp. Med. Biol. (2007) 594:159-166.
- HARTMAN DJ, HOOGENRAAD NJ, CONDRON R, HOJ PJ: Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro. Proc. Natl. Acad. Sci. USA (1992) 89:3394-3398.
- ELLIS RJ, HARTL F: Protein folding in the cell: competing models of chaperonin function. FASEB J. (1996) 10:20-26.
- CZARNECKA AM, CAMPANELLA C, ZUMMO G, CAPPELLO F: Heat shock protein 10 and signal transduction: a “capsula eburnea” of carcinogenesis? Cell Stress Chaperonins (2006) 11:287-294.
- MELLE C, BOGUMIL R, ERNST G et al.: Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics (2006) 6:2600-2608.
- CZARNECKA AM, CAMPANELLA C, ZUMMO G, CAPPELLO F: Mitochondrial chaperonins in cancer: from molecular biology to clinical diagnostics. Cancer Biol. Ther. (2006) 5:714-720.
- MORTON H, ROLFE B, CLUNIE GJ: An early pregnancy factor detected in human serum by the rosette inhibition test. Lancet (1977) 1:394-397.
- CAVANAGH AC: Identification of early pregnancy factor as chaperonin 10: implications for understanding its role. Rev. Reprod. (1996) 1:28-32.
- AKYOL S, GERCEL-TAYLOR C, REYNOLDS LC, TAYLOR DD: HSP-10 in ovarian cancer: expression and suppression of T-cell signaling. Gynecol. Oncol. (2006) 101:481-486.
- MORTON H, MCKAY D A, MURPHY RM et al.: Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin graft survival time in rats. Immunol. Cell Biol. (2000) 78:603-607.
- ZHANG B, HARNESS J, SOMODEVILLA-TORRES MJ et al.: Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151. J. Neurol. Sci. (2000) 182:5-15.
- HARNESS J, CAVANAGH A, MORTON H, MCCOMBE P: A protective effect of early pregnancy factor on experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J. Neurol. Sci. (2003) 216:33-41.
- ZHANG B, WALSH M D, NGUYEN KB et al.: Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice. J. Neurol. Sci. (2003) 212:37-46.
- JOHNSON BJ, LE TT, DOBBIN CA et al.: Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J. Biol. Chem. (2005) 280:4037-4047.
- SANDOR F, BUC M: Toll-like receptors. I. Structure, function and their ligands. Folia Biologica (Praha) (2005) 51:148-156.
- SANDOR F, BUC M: Toll-like receptors. II. Distribution and pathways involved in TLR signaling. Folia Biologica (Praha) (2005) 51:188-197.
- SANDOR F, BUC M: Toll-like receptors. III. Biological significance and impact for human medicine. Folia Biologica (Praha) (2005) 51:198-203.
- KAWAI T, AKIRA S: TLR signaling. Cell Death Differ. (2006) 13:816-825.
- CARMODY RJ, CHEN YH: NF-κB: activation and regulation during toll-like receptor signaling. Cell Mol. Immunol. (2007) 4:31-41.
- VANAGS D, WILLIAMS B, JOHNSON B et al.: Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet (2006) 368:855-863.
- RYAN M, NAYLOR DJ, HOOGENRAAD NJ, HOJ PB: Affinity purification, overexpression, and characterization of chaperonin 10 homologues synthesized with and without N-terminal acetylation. J. Biol. Chem. (1995) 15:22037-22043.
- SOMEDEVILLA-TORRES MJ, MORTON H, ZHANG B, REID S, CAVANAGH AC: Purification and characterisation of functional early pregnancy factor expressed in Sf9 insect cells and in Escherichia coli. Protein Expr. Purif. (2003) 32:276-287.
- ATHANASAS-PLATSIS S, SOMODEVILLA-TORRES MJ, MORTON H, CAVANAGH AC: Investigation of the immunocompetent cells that bind early pregnancy factor and preliminary studies of the early pregnancy factor target molecule. Immunol. Cell Biol. (2004) 82:361-369.
- HUNT JF, WEAVER AJ, LANDRY SJ, GIERASCH L, DEISENHOFER J: The crystal structure of the GroES co-chaperonin at 2.8 A resolution. Nature (1996) 379:37-45.
- XU Z, HORWICH A L, SIGLER PB: The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature (1997) 388:741-750.
- GUIDRY JJ, SHEWMAKER F, MASKOS K, LANDRY S, WITTUNG-STAFSHEDE P: Probing the interface in a human co-chaperonin heptamer: residues disrupting oligomeric unfolded state identified. BMC Biochem. (2003) 4:14.
- RICHARDSON A, SCHWAGER F, LANDRY SJ, GEORGOPOULOS C: The importance of a mobile loop in regulating chaperonin/co-chaperonin interaction: humans versus Escherichia coli. J. Biol. Chem. (2001) 276:4981-4987.
- JARES-ERIJMAN EA, JOVIN TM: Imaging molecular interactions in living cells by FRET microscopy. Curr. Opin. Chem. Biol. (2006) 10:409-416.
- YARMOLA EG, BUBB MR: Profilin: emerging concepts and lingering misconceptions. Trends Biochem. Sci. (2006) 31:197-205.
- MISRA UK, DEEDWANIA R, PIZZO SV: Activation and cross-talk between Akt, NF-κB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78. J. Biol. Chem. (2006) 281:13694-13707.
- SEALE JW, GOROVITS BM, YBARRA J, HOROWITZ PM: Reversible oligomerization and denaturation of the chaperonin GroES. Biochemistry (1996) 35:4079-4083.
- BISCHOF RJ, SNIBSON K, SHAW R, MEEUSEN EN: Induction of allergic inflammation in the lungs of sensitized sheep after local challenge with house dust mite. Clin. Exp. Allergy (2003) 33:367-375.
- KOUMOUNDOUROS E, BISCHOF RJ, MEEUSEN EN, MAREELS IM, SNIBSON KJ: Chronic airway disease: deteriorating pulmonary function in sheep associated with repeated challenges of house dust mite. Exp. Lung Res. (2006) 32:321-330.
- TSAN MF, GAO B: Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. (2004) 286:C739-C744.
- DE GRAAF R, KLOPPENBURG G, KITSLAAR PJ, BRUGGEMAN CA, STASSEN F: Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect. (2006) 8:1859-1865.
- GAO B, TSAN MF: Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of TNF-α release by murine macrophages. J. Biol. Chem. (2003) 278:174-179.
- YE Z, GAN YH: Flagellin contamination of recombinant heat shock protein 70 is responsible for its activity on T cells. J. Biol. Chem. (2007) 282:4479-4484.
- TRIANTAFILOU M, MORATH S, MACKIE A, HARTUNG T, TRIANTAFILOU K: Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J. Cell Sci. (2004) 117:4007-4014.
- HANSEN JJ, BROSS P, WESTERGAARD M et al.: Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum. Genet. (2003) 112:71-77.
- KIM SW, LEE JK: NO-induced downregulation of HSP10 and HSP60 expression in the postischemic brain. J. Neurosci. Res. (2007) 85:1252-1259.
- HALCOX JP, DEANFIELD J, SHAMAEI-TOUSI A et al.: Circulating human heat shock protein 60 in the blood of healthy teenagers: a novel determinant of endothelial dysfunction and early vascular injury? Arterioscler. Thromb. Vasc. Biol. (2005) 25:141-142.
- SHAMAEI-TOUSI A, STEPHENS JW, BIN R et al.: Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur. Heart J. (2006) 27:1565-1570.
- WHEELER DS, LAHNI P, ODOMS K et al.: Extracellular heat shock protein 60 (Hsp60) levels in children with septic shock. Inflamm. Res. (2007) 56:216-219.
- HABICH C, KEMPE K, VAN DER ZEE R et al.: Heat shock protein 60: specific binding of lipopolysaccharide. J. Immunol. (2005) 174:1298-1305.
- HABICH C, BURKART V: Heat shock protein 60: regulatory role on innate immune cells. Cell Mol. Life Sci. (2007) 64:742-751.
- MCINNES IB, SCHETT G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. (2007) 7:429-442.
- HUANG Q, MA Y, ADEBAYO A, POPE RM: Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum. (2007) 56:2192-2201.
- SARASTE M, VÄISÄNEN S, ALANEN A et al.: Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gend. Med. (2007) 4:45-55.
- HOLMØY T: Immunopathogenesis of multiple sclerosis: concepts and controversies. Acta Neurol. Scand. Suppl. (2007) 187:39-45.
- KRAKAUER M, SORENSEN PS, SELLEBJERG F: CD4(+) memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis. J. Neuroimmunol. (2006) 181:157-164.
- WOLF NA, AMOUZEGAR TK, SWANBORG RH: Synergistic interaction between Toll-like receptor agonists is required for induction of experimental autoimmune encephalomyelitis in Lewis rats. J. Neuroimmunol. (2007) 185:115-122.
- KARNI A, ABRAHAM M, MONSONEGO A et al.: Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. (2006) 177:4196-4202.
- VAKNIN-DEMBINSKY A, WEINER HL: Relationship of immunologic abnormalities and disease stage in multiple sclerosis: implications for therapy. J. Neurol. Sci. (2007) 259:90-94.
- LAFON M, MEGRET F, LAFAGE M, PREHAUD C: The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA. J. Mol. Neurosci. (2006) 29:185-194.
- KREMENCHUTZKY M, MORROW S, RUSH C: The safety and efficacy of IFN-β products for the treatment of multiple sclerosis. Expert Opin. Drug Saf. (2007) 6(3):279-288.
- BROADLEY S, JOHNSON B, FEENEY D, SHAKIB S: Phase Ia and Ib clinical trials of chaperonin 10 in healthy volunteers and patients with multiple sclerosis. J. Neurol. Sci. (2005) 238(Supppl. 1):S223.
- NGOC PL, GOLD DR, TZIANABOS AO, WEISS ST, CELEDÓN JC: Cytokines, allergy, and asthma. Curr. Opin. Allergy Clin. Immunol. (2005) 5:161-166.
- YANG IA, FONG KM, HOLGATE ST, HOLLOWAY JW: The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr. Opin. Allergy Clin. Immunol. (2006) 6:23-28.
- DUEZ C, GOSSET P, TONNEL AB: Dendritic cells and Toll-like receptors in allergy and asthma. Eur. J. Dermatol. (2006) 16:12-16.
- NIGO YI, YAMASHITA M, HIRAHARA K et al.: Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc. Natl. Acad. Sci. USA (2006) 103:2286-2291.
- SUKKAR MB, XIE S, KHORASANI NM et al.: Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J. Allergy Clin. Immunol. (2006) 118:641-648.
- MEGHJI S, WHITE P A, NAIR S P et al.: Mycobacterium tuberculosis chaperonin 10 stimulates bone resorption: a potential contributory factor in Pott's disease. J. Exp. Med. (1997) 186:1241-1246.
- LEMBO PM, GRAZZINI E, GROBLEWSKI et al.: Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat. Neurosci. (2002) 5:201-209.
Patents
- CBIO LTD: WO2005067959 (2005).
- UNIV. QUEENSLAND: US6117421 (2000).
- CBIO LTD: WO2004041300 (2004).
- UNIV. QUEENSLAND: WO20043033 (2000).
- CBIO LTD: WO2007006095 (2007).
- CBIO LTD: WO2007025343 (2007).
- CBIO LTD: WO2007045046 (2007).
- UNIV. QUEENSLAND: US2003175280 (2003).
- JANSSEN PHARMACEUTICA NV: WO03005036 (2003).